Susan T Paulukonis1, James R Eckman2, Angela B Snyder3, Ward Hagar4, Lisa B Feuchtbaum5, Mei Zhou6, Althea M Grant7, Mary M Hulihan7. 1. Public Health Institute, Oakland, CA. 2. Emory University, Atlanta, GA. 3. Georgia State University, Department of Public Management and Policy, Atlanta, GA; Georgia State University, Georgia Health Policy Center, Atlanta, GA. 4. University of California San Francisco Benioff Children's Hospital Oakland, Oakland, CA. 5. California Department of Public Health, Genetic Disease Screening Program, Richmond, CA. 6. Georgia State University, Georgia Health Policy Center, Atlanta, GA. 7. Centers for Disease Control and Prevention, Division of Blood Disorders, Atlanta, GA.
Abstract
OBJECTIVE: Population-based surveillance data from California and Georgia for years 2004 through 2008 were linked to state death record files to determine the all-cause death rate among 12,143 patients identified with sickle cell disease (SCD). METHODS: All-cause death rates, by age, among these SCD patients were compared with all-cause death rates among both African Americans and the total population in the two states. All-cause death rates were also compared with death rates for SCD derived from publicly available death records: the compressed mortality files and multiple cause of death files. RESULTS: Of 12,143 patients identified with SCD, 615 patients died. The all-cause mortality rate for the SCD population was lower than the all-cause mortality rate among African Americans and similar to the total population all-cause mortality rates from birth through age 4 years, but the rate was higher among those with SCD than both the African American and total population rates from ages 5 through 74 years. The count of deceased patients identified by using population-based surveillance data (n=615) was more than twice as high as the count identified in compressed mortality files using SCD as the underlying cause of death alone (n=297). CONCLUSION: Accurate assessment of all-cause mortality and age at death requires long-term surveillance via population-based registries of patients with accurately diagnosed SCD.
OBJECTIVE: Population-based surveillance data from California and Georgia for years 2004 through 2008 were linked to state death record files to determine the all-cause death rate among 12,143 patients identified with sickle cell disease (SCD). METHODS: All-cause death rates, by age, among these SCDpatients were compared with all-cause death rates among both African Americans and the total population in the two states. All-cause death rates were also compared with death rates for SCD derived from publicly available death records: the compressed mortality files and multiple cause of death files. RESULTS: Of 12,143 patients identified with SCD, 615 patients died. The all-cause mortality rate for the SCD population was lower than the all-cause mortality rate among African Americans and similar to the total population all-cause mortality rates from birth through age 4 years, but the rate was higher among those with SCD than both the African American and total population rates from ages 5 through 74 years. The count of deceased patients identified by using population-based surveillance data (n=615) was more than twice as high as the count identified in compressed mortality files using SCD as the underlying cause of death alone (n=297). CONCLUSION: Accurate assessment of all-cause mortality and age at death requires long-term surveillance via population-based registries of patients with accurately diagnosed SCD.
Authors: O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug Journal: N Engl J Med Date: 1994-06-09 Impact factor: 91.245
Authors: F M Gill; L A Sleeper; S J Weiner; A K Brown; R Bellevue; R Grover; C H Pegelow; E Vichinsky Journal: Blood Date: 1995-07-15 Impact factor: 22.113
Authors: Mary M Hulihan; Lisa Feuchtbaum; Lanetta Jordan; Russell S Kirby; Angela Snyder; William Young; Yvonne Greene; Joseph Telfair; Ying Wang; William Cramer; Ellen M Werner; Kristy Kenney; Melissa Creary; Althea M Grant Journal: Genet Med Date: 2014-07-03 Impact factor: 8.822
Authors: Arch G Mainous; Peter J Carek; Kim Lynch; Rebecca J Tanner; Mary M Hulihan; Jacquelyn Baskin; Thomas D Coates Journal: J Am Board Fam Med Date: 2018 Sep-Oct Impact factor: 2.657
Authors: Julie Kanter; Wally R Smith; Payal C Desai; Marsha Treadwell; Biree Andemariam; Jane Little; Diane Nugent; Susan Claster; Deepa G Manwani; Judith Baker; John J Strouse; Ifeyinwa Osunkwo; Rosalyn W Stewart; Allison King; Lisa M Shook; John D Roberts; Sophie Lanzkron Journal: Blood Adv Date: 2020-08-25
Authors: Amanda B Payne; Laura A Schieve; Karon Abe; Mary Hulihan; W Craig Hooper; Lewis L Hsu Journal: Public Health Rep Date: 2022-01-21 Impact factor: 2.792